Meadow Oaks of Roseville

This report details the findings of a complaint investigation conducted on March 20, 2026, regarding allegations of staff misconduct. All three allegations—inappropriate staff speech, failure to respond to call buttons, and rough handling of residents—were found to be 'Unfounded' based on interviews and record reviews.

The facility underwent a Required-1 Year Inspection on February 26, 2026. The Licensing Program Analyst observed that the facility maintained good standards across various areas, including cleanliness, safety equipment, and recordkeeping. No deficiencies were cited during this inspection.

The inspection was a Case Management visit conducted on 12/15/2025. The primary findings relate to an incident involving a resident's fall and subsequent care management failures. One Type B deficiency was cited regarding the failure to ensure appropriate medical and dental care for residents.

The case management visit was conducted on 9/25/25, following a death notification for a resident (R1) on 9/18/25. The analyst reviewed resident records and spoke with the administrator and director. The report explicitly states that no deficiencies were noted during the inspection.

The case management visit conducted on August 19, 2025, was related to an incident report from August 8, 2025, concerning a resident fall. The Licensing Program Analyst noted that no deficiencies were found during today's inspection. The LPA will continue to gather additional information.

The report documents a Case Management conference held on 5/22/25 to review the facility's compliance plan established on 2/6/25. Discussions focused on continued non-compliance issues and enhancing the existing plan to address medication errors and communication gaps. No specific deficiencies were cited in the provided text.

FACILITY EVALUATION REPORT

The inspection was conducted to review a recently reported medication error and discuss fall risks. One deficiency was cited related to medication administration protocols. The facility was noted to have addressed the medication error through increased monitoring and record-keeping changes.